US Stock MarketDetailed Quotes

PRQR ProQR Therapeutics

Watchlist
  • 1.715
  • +0.175+11.36%
Trading Apr 29 12:29 ET
180.44MMarket Cap-4.69P/E (TTM)

About ProQR Therapeutics Company

ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. Platenburg, Henri A. Termeer, and Domenico Valerio on February 21, 2012, and is headquartered in Leiden, the Netherlands.

Company Profile

SymbolPRQR
Company NameProQR Therapeutics
Listing DateSep 18, 2014
Issue Price13.00
Founded2012
CEOMr. Daniel de Boer
MarketNASDAQ
Employees166
Fiscal Year Ends12-31
AddressZernikedreef 9
CityLeiden
ProvinceZuid-Holland
CountryNetherlands (the)
Zip Code2333 CK
Phone31-88-166-70-00
Websitehttp://www.proqr-tx.com

Company Executives

  • Name
  • Position
  • Salary
  • Daniel de Boer
  • Chief Executive Officer and Executive Director
  • 2.44M
  • Sheila Sponselee
  • Chief People and Operations Officer
  • --
  • Rene Beukema
  • Executive Director, Chief Corporate Development Officer and General Counsel
  • 1.31M
  • Jurriaan Dekkers
  • Chief Financial Officer
  • --
  • Dr. Gerard Platenburg, PhD
  • Chief Scientific Officer and and Executive Director
  • --
  • Dr. James S. Shannon, M.D.,M.R.C.P.
  • Chairman of the Board
  • 132.00K
  • Theresa M. Heggie
  • Independent Director
  • 271.00K
  • Alison F. Lawton
  • Independent Director
  • 126.00K
  • Bart Filius, M.B.A.
  • Independent Director
  • 127.00K
  • Dr. Martin Maier, PhD
  • Independent Director
  • --
  • Dr. Dinko Valerio, PhD
  • Independent Director
  • 150.00K
  • Dr. Begona Carreno, PhD
  • Independent Director
  • 84.00K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Collegium Pharmaceutical
COLL
27.590
Cars.com
CARS
12.020
Halozyme Therapeutics
HALO
61.490
4
Lantheus
LNTH
104.110
5
Precision Drilling
PDS
43.660
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.